References
1.
Dellaripa PF. Interstitial lung disease in the connective tissue diseases; a paradigm shift in diagnosis and treatment. Clin Immunol.
2018 Jan;186:71-73.
doi:10.1016/j.clim.2017.09.015.
2.
Aburto M,
Herráez I,
Iturbe D,
Jiménez-Romero A.
Diagnosis of Idiopathic Pulmonary Fibrosis: Differential Diagnosis. Med Sci (Basel).
2018;6(3):73.
Published 2018 Sep 4.
doi:10.3390/medsci6030073
3. Torres PPTES,
Rabahi MF,
Moreira MAC,
Meirelles GSP,
Marchiori E.
Usual interstitial pneumonia: typical,
possible,
and "inconsistent" patterns. J Bras Pneumol.
2017;43(5):393-398.
4.
Pereira CA,
Gimenez A,
Kuranishi L,
Storrer K.
Chronic hypersensitivity pneumonitis. J Asthma Allergy.
2016;9:171-181.
Published 2016 Sep 21.
doi:10.2147/JAA.S81540
5.
Assayag D,
Elicker BM,
Urbania TH,
et al.
Rheumatoid arthritis-associated interstitial lung disease: radiologic identification of usual interstitial pneumonia pattern. Radiology.
2014;270(2):583-8.
6.
Cemal B,
Konuk S.
Management of interstitial lung disease associated with rheumatoid arthritis. Austin Intern Med3(3): id1032 (2018).
7.
Mueller-Mang C, Grosse C, Schmid K, Stiebellehner L, A.
Bankier A. What Every Radiologist Should Know about Idiopathic Interstitial Pneumonias.RadioGraphics200727:3,595-615
8. Giacomelli R,
Liakouli V, Berardicurti O, Ruscitti P, Di Benedetto P, Carubbi F et al. Interstitial lung disease in systemic sclerosis: current and future treatment. Rheum Intern.June 2017, Volume 37, Issue 6, pp 853–863.
9.
Khanna D,
Seibold J,
Goldin J,
Tashkin DP,
Furst DE,
Wells A.
Interstitial lung disease points to consider for clinical trials in systemic sclerosis. Rheumatology (Oxford).
2017;56(suppl_5):v27-v32.
10.
Wuyts WA,
Cavazza A,
Rossi G,
Bonella F,
Sverzellati N,
Spagnolo P.
Differential diagnosis of usual interstitial pneumonia: when is it truly idiopathic? Eur Respir Rev.
2014 Sep;23(133):308-19.
doi: 10.1183/09059180.00004914.
11.
Lynch DA, Sverzellati N,Travis WD et al. Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper. Lancet Respir Med. 2018 Feb;6(2):138-153;doi: 10.1038/s41598-018-34230-z.
12.
American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. American Journal of Respiratory and Critical Care Medicine.
2002; 165(2),
pp.
277–304.
13. Travis WD,
Costabel U,
Hansell DM,
et al.
An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med.
2013;188(6):733-48.
14.
Kim H,
Yoon SH,
Hong H,
Hahn S,
Goo JM.
Diagnosis of Idiopathic Pulmonary Fibrosis in a Possible Usual Interstitial Pneumonia Pattern: a meta-analysis. Sci Rep.
2018;8(1):15886.
Published 2018 Oct 26; doi:10.1038/s41598-018-34230-z.
15.
Wuyts WA,
Cavazza A,
Rossi G,
Bonella F,
Sverzellati N,
Spagnolo P.
European Respiratory Review.
2014; 23: 308-319; doi:10.1183/09059180.00004914.
16.
Smith M,
Dalurzo M,
Panse P,
Parish J,
Leslie K.
Usual interstitial pneumonia-pattern fibrosis in surgical lung biopsies.
Clinical,
radiological and histopathological clues to aetiology. J Clin Pathol.
2013;66(10):896-903.
17.
Fischer A, Antoniou KM, Brown KK et al.
European Respiratory Journal 2015; 46: 976-987; doi:10.1183/13993003.00150-2015.
18. Wells AU.
European Respiratory Review.
2013; 22: 158-162; doi:10.1183/09059180.00001213.
19. Rivera-Ortega P,
Hayton C,
Blaikley J,
Leonard C,
Chaudhuri N.
Nintedanib in the management of idiopathic pulmonary fibrosis: clinical trial evidence and real-world experience. Ther Adv Respir Dis.
2018;12:1753466618800618